Sunday, 12 Apr 2026
Home
Stock Market
Product / Services
Press Releases
Company Announcement
Partnerships
Featured Article
Announces
Crypto
Price
Pepeto
News
Prediction
Market
Targets
Search
Home
Stock Market
Product / Services
Press Releases
Company Announcement
Partnerships
Featured Article
Follow US
BioNTechs
Company Announcement
April 11, 2026
BioNTechs und DualityBios Antikörper-Wirkstoff-Konjugat-Kandidat Trastuzumab Pamirtecan zeigte klinisch relevante Wirksamkeit bei Patientinnen mit rezidivierendem HER2-exprimierendem Gebärmutterkrebs
